Cite
Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study)
MLA
Célia Lloret-Linares, et al. “Exploring Venlafaxine Pharmacokinetic Variability with a Phenotyping Approach, a Multicentric French-Swiss Study (MARVEL Study).” BMC Pharmacology and Toxicology, vol. 18, no. 1, Nov. 2017, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s40360-017-0173-2.
APA
Célia Lloret-Linares, Youssef Daali, Sylvie Chevret, Isabelle Nieto, Fanny Molière, Philippe Courtet, Florence Galtier, Raphaëlle-Marie Richieri, Sophie Morange, Pierre-Michel Llorca, Wissam El-Hage, Thomas Desmidt, Frédéric Haesebaert, Philippe Vignaud, Jerôme Holtzmann, Jean-Luc Cracowski, Marion Leboyer, Antoine Yrondi, Fabienne Calvas, … Frank Bellivier. (2017). Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study). BMC Pharmacology and Toxicology, 18(1), 1–12. https://doi.org/10.1186/s40360-017-0173-2
Chicago
Célia Lloret-Linares, Youssef Daali, Sylvie Chevret, Isabelle Nieto, Fanny Molière, Philippe Courtet, Florence Galtier, et al. 2017. “Exploring Venlafaxine Pharmacokinetic Variability with a Phenotyping Approach, a Multicentric French-Swiss Study (MARVEL Study).” BMC Pharmacology and Toxicology 18 (1): 1–12. doi:10.1186/s40360-017-0173-2.